A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers
Crossref DOI link: https://doi.org/10.1007/s10840-014-9966-z
Published Online: 2015-02-01
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ezekowitz, Michael D.
Ellenbogen, Kenneth A.
DiMarco, John P.
Kaszala, Karoly
Boddy, Alexander
P., Gregory Geba
Koren, Andrew
License valid from 2015-02-01